您的购物车当前为空
别名 PRN1008
Rilzabrutinib (PRN1008) 是一种可逆的、选择性的、有口服活性的布鲁顿氏酪氨酸激酶(BTK)共价抑制剂,其 IC50=1.3 nM。


为众多的药物研发团队赋能,
让新药发现更简单!
Rilzabrutinib (PRN1008) 是一种可逆的、选择性的、有口服活性的布鲁顿氏酪氨酸激酶(BTK)共价抑制剂,其 IC50=1.3 nM。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 818 | In Stock | |
| 5 mg | ¥ 1,980 | In Stock | |
| 10 mg | ¥ 3,270 | In Stock | |
| 25 mg | ¥ 5,230 | In Stock | |
| 50 mg | ¥ 7,190 | In Stock | |
| 100 mg | ¥ 9,680 | In Stock | |
| 200 mg | ¥ 12,800 | In Stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 2,970 | In Stock |
Rilzabrutinib 相关产品
| 产品描述 | Rilzabrutinib (PRN1008) is a reversible covalent, selective and oral active inhibitor of Bruton’s Tyrosine Kinase (BTK)(IC50 of 1.3 nM). |
| 靶点活性 | ITK:440 nM, BTK (Ramos B cell):8 ± 2 nM, ERBB4:11.3 nM, ERBB2:3900 nM, BTK:1.3 nM, FcγR (Monocyte):56 ± 45 nM, BLK:6.3 nM, EGFR:520 nM, TXK:1.2 ± 0.3 nM, RLK:1.2 nM, BMX?kinase:1.0 ± 0.1 nM, TEC:0.8 nM, BCR (B cell):5 ± 2 nM |
| 别名 | PRN1008 |
| 分子量 | 665.76 |
| 分子式 | C36H40FN9O3 |
| CAS No. | 1575596-29-0 |
| Smiles | CC(C)(\C=C(/C#N)C(=O)N1CCC[C@H](C1)n1nc(-c2ccc(Oc3ccccc3)cc2F)c2c(N)ncnc12)N1CCN(CC1)C1COC1 |
| 密度 | 1.39 g/cm3 (Predicted) |
| 颜色 | White |
| 物理性状 | Solid |
| 存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 240 mg/mL (360.49 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 5 mg/mL (7.51 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容